MIS-C sequel to COVID-19 infection, diagnostic challenge and management. A case report

Authors

  • Subash Paudeal 2nd Year Resident, MD Pediatrics, Patan Academy of Health Sciences, Lalitpur, Nepal.
  • Sunil Kumar Das 2nd Year Resident, MD General Practice and Emergency Medicine, Patan Academy of Health Sciences, Lalitpur Nepal.

Keywords:

COVID-19, diagnosis, MISC-C

Abstract

Multisystem inflammatory syndrome in children (MIS-C) is a rare sequel to severe acute respiratory syndrome coronavirus (SARS-CoV-2). Clinical picture of MIS-C includes multi system inflammation alongside fever and severe illness with laboratory evidence of raised inflammatory markers. MIS-C may resemble toxic shock syndrome, complete or incomplete Kawasaki disease and macrophage activation syndrome. Actual management of MIS-C is yet to be formulated, currently treatment is supportive only. In addition, as MIS-C is a new clinical entity we do not know about its long-term prognosis.

Abstract
19
PDF
0

Downloads

Published

2021-07-01

How to Cite

MIS-C sequel to COVID-19 infection, diagnostic challenge and management. A case report. (2021). Journal of General Practice and Emergency Medicine of Nepal, 8(11), 55-58. https://nepjol.info/index.php/jgpemn/article/view/89639

Issue

Section

Case Reports/Case Series

How to Cite

MIS-C sequel to COVID-19 infection, diagnostic challenge and management. A case report. (2021). Journal of General Practice and Emergency Medicine of Nepal, 8(11), 55-58. https://nepjol.info/index.php/jgpemn/article/view/89639